Ryoichi Onozato

709 citations
22 papers · 536 indexed · h-index 12
Topics
Lung Cancer Treatments and Mutations (9 papers)Lung Cancer Research Studies (5 papers)Lung Cancer Diagnosis and Treatment (5 papers)
Journals
SHILAP Revista de lepidopterologíaJournal of Pharmaceutical SciencesAnnals of Surgical Oncology
Partner nations
Japan

In The Last Decade

Ryoichi Onozato

22 papers receiving 526 citations

Peers

Ryoichi Onozato
Comparison fields: 5 of 53
  • Pulmonary and Respiratory Medicine 284
  • Oncology 258
  • Molecular Biology 221
  • Cancer Research 118
  • Epidemiology 66
Replace Christine M. Heske with:
Christine M. Heske United States
Olsi Gjyshi United States
Manuel P. Jiménez-García Spain
Sean Clark-Garvey United States
Sushma Jonna United States
Suhong Xie China
Jérôme Alexandre France
Donghua Gu China
Bianca Cheaib France
Giovanna Speranza United States
Ryoichi Onozato relative to Christine M. Heske United States Christine M. Heske's profile →
Citations per field
00.5×
Christine M. Heske · 1×
Citations per year

Countries citing papers authored by Ryoichi Onozato

Since Specialization
Citations

This map shows the geographic impact of Ryoichi Onozato's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryoichi Onozato with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryoichi Onozato more than expected).

Fields of papers citing papers by Ryoichi Onozato

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryoichi Onozato. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryoichi Onozato. The network helps show where Ryoichi Onozato may publish in the future.

Co-authorship network of co-authors of Ryoichi Onozato

This figure shows the co-authorship network connecting the top 25 collaborators of Ryoichi Onozato. A scholar is included among the top collaborators of Ryoichi Onozato based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryoichi Onozato. Ryoichi Onozato is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 4
2 1
3 1
4 15
5 2
6 14
7 5
8
Prognostic significance of PD-L1 expression and tumor infiltrating lymphocytes in large cell neuroendocrine carcinoma of lung.
27
9 37
10 26
11
Src kinase-associated phosphoprotein2 expression is associated with poor prognosis in non-small cell lung cancer.
11
12 55
13 1
14 47
15 1
16 8
17 196
18 16
19 45
20 14

About Ryoichi Onozato

Ryoichi Onozato is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Geriatrics and Gerontology, having authored 22 papers that have together received 536 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (9 papers), Lung Cancer Research Studies (5 papers) and Lung Cancer Diagnosis and Treatment (5 papers). The work is most often cited by research in Geriatrics and Gerontology (44 citations), Oncology (258 citations) and Pulmonary and Respiratory Medicine (284 citations). Ryoichi Onozato has collaborated with scholars based in Japan. Frequent co-authors include Hiroyuki Kuwano, Takayuki Kosaka, Tetsuya Mitsudomi, Yasushi Yatabe, Toshiki Yajima, Akira Mogi, Ei Yamaki, Takehiko Yokobori, Shigebumi Tanaka and Bolag Altan. Their work appears in journals such as SHILAP Revista de lepidopterología, Journal of Pharmaceutical Sciences and Annals of Surgical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026